| Name | Title | Contact Details |
|---|
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
Synarc enables its clients to demonstrate the efficacy of new therapies across a broad range of therapeutic areas through highly specialized medical imaging and molecular marker techniques.
Navicure has chosen to focus exclusively on the needs of practices and institutions performing physician billing.
Tillges Certified Orthotic Prothstetic is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Addiction Prevention is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.